LincRNA-p21 activates endoplasmic reticulum stress and inhibits hepatocellular carcinoma

Ning Yang1, Yong Fu1, Haibin Zhang1

  • 1Hepatobiliary Surgery Department V, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.

Oncotarget
|August 26, 2015
PubMed

Insights

Long non-coding RNA p21 (lincRNA-p21) acts as a tumor suppressor in hepatocellular carcinoma. Its downregulation correlates with advanced disease and poor survival, while its restoration inhibits cancer growth and enhances treatment response by promoting ER stress and apoptosis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • LincRNA-p21, a downstream transcript of p53, regulates gene expression and is involved in various cellular processes.
  • The specific role of lincRNA-p21 in human hepatocellular carcinoma (HCC) has not been fully elucidated.

Purpose of the Study:

  • To investigate the function and mechanism of lincRNA-p21 in human hepatocellular carcinoma.
  • To determine if lincRNA-p21 can serve as a prognostic marker or therapeutic target for HCC.

Main Methods:

  • Analysis of lincRNA-p21 expression in HCC tissues and correlation with clinical parameters.
  • In vitro studies involving lincRNA-p21 knockdown and overexpression in HCC cell lines (HepG2, Huh7, Bel-7042).
  • In vivo tumor xenograft experiments and mechanistic studies focusing on ER stress and apoptosis.

Main Results:

  • LincRNA-p21 expression was downregulated in HCC tissues and associated with advanced stage and poor prognosis.
  • LincRNA-p21 knockdown promoted HCC cell proliferation and colony formation in vitro.
  • LincRNA-p21 overexpression inhibited HCC cell growth in vivo and sensitized cells to sorafenib treatment, partly through ER stress induction and enhanced apoptosis.

Conclusions:

  • LincRNA-p21 functions as a tumor-suppressive lncRNA in human hepatocellular carcinoma.
  • LincRNA-p21's tumor-suppressive effects are mediated by the promotion of ER stress, leading to apoptosis.
  • LincRNA-p21 represents a potential prognostic biomarker and therapeutic target for HCC.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.9K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
Role of ER in the Secretory Pathway01:17

Role of ER in the Secretory Pathway

Eukaryotic cells have a special pathway that enables communication between various intracellular membrane-bound compartments and also with the extracellular environment. This pathway is termed as the secretory pathway.
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...
7.8K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
7.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.0K